Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model.

Clinicians should be aware that the free fraction changes when phenytoin exposure changes. A mechanistic binding model may facilitate prediction of free phenytoin concentrations from total concentrations, for example for dose individualization in the clinic.